Gossamer Bio (GOSS) Short-term Investments (2018 - 2026)
Gossamer Bio (GOSS) recorded Short-term Investments of $15.88 million in Q2 2026, down 91.5% from $186.61 million a year earlier and down 72.7% from the prior quarter.
Powered by 
Analysis
Gossamer Bio (GOSS) Short-term Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, Gossamer Bio reported Short-term Investments of $99.2 million, down 60.1% from FY2024.
- Annual Short-term Investments has a five-year compound annual growth rate of 30.1% (FY2020 to FY2025).
- Across earlier years, Short-term Investments came in at $248.44 million in FY2024 (-6.0%), $264.32 million in FY2023 (+83.9%), $143.71 million in FY2022 (+1.3%) and $141.82 million in FY2021 (+433.7%).
- The Q2 2026 figure is the lowest quarterly Short-term Investments since Q1 2021.
- On a year-over-year basis, Short-term Investments has declined for five consecutive quarters, with an average decline of 34.1% over the last eight quarters.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 873.1% in Q1 2022, against a decline of 91.5% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $58.19 million (Q1 2026), $99.2 million (Q4 2025) and $171.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Gossamer Bio | 37.84 Mn | -435.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.88 Mn |
| Mar 31, 2026 | 58.19 Mn |
| Dec 31, 2025 | 99.20 Mn |
| Sep 30, 2025 | 171.29 Mn |
| Jun 30, 2025 | 186.61 Mn |
| Mar 31, 2025 | 228.91 Mn |
| Dec 31, 2024 | 248.44 Mn |
| Sep 30, 2024 | 298.57 Mn |
| Jun 30, 2024 | 267.61 Mn |
| Mar 31, 2024 | 205.53 Mn |
| Dec 31, 2023 | 264.32 Mn |
| Sep 30, 2023 | 246.28 Mn |
| Jun 30, 2023 | 125.12 Mn |
| Mar 31, 2023 | 136.61 Mn |
| Dec 31, 2022 | 143.71 Mn |
| Sep 30, 2022 | 150.91 Mn |
| Jun 30, 2022 | 127.85 Mn |
| Mar 31, 2022 | 132.72 Mn |
| Dec 31, 2021 | 141.82 Mn |
| Sep 30, 2021 | 152.55 Mn |
API Access
Gossamer Bio Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();